| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |